Assessment of the Prosthetic Replacement of Ocular Surface Ecosystem (PROSE) scleral lens on visual acuity for corneal irregularity and ocular surface disease
- PMID: 29425812
- DOI: 10.1016/j.jtos.2018.01.003
Assessment of the Prosthetic Replacement of Ocular Surface Ecosystem (PROSE) scleral lens on visual acuity for corneal irregularity and ocular surface disease
Abstract
Purpose: To describe changes in visual acuity in patients fit with the Prosthetic Replacement of Ocular Surface Ecosystem (PROSE) with irregular corneas compared to those with ocular surface disease, as well as describe patient demographics and fitting indications for PROSE at an academic medical center.
Methods: A retrospective chart review from 2010 to 2016 on a total of 825 eyes from 493 patients fitted with a PROSE lens, and grouped by etiology, either irregular cornea/dystrophy or ocular surface disease and associated sub-etiologies. We compared best corrected visual acuity (BCVA) before and after PROSE fitting.
Results: The irregular cornea group (n = 262 eyes) included corneal scar (n = 57), dystrophy (n = 17), post-operative corneal irregularity (n = 70), and primary ectasia (n = 118). The OSD group included 563 eyes. For all etiologies combined, mean BCVA prior to PROSE fitting compared to after improved by 0.28 logMAR (p < .001). In the irregular cornea group, the mean BCVA improved by 0.46 logMAR (p < .001), while the improvement in BCVA for the OSD group was 0.20 logMAR (p < .001). All etiologies in the irregular cornea group demonstrated improvement in BCVA (p < .05) with the exception of post-PRK (n = 2). BCVA improvement was found for all sub-etiologies in the OSD subgroup (p < .05).
Conclusions: PROSE treatment had a positive impact on visual acuity for a wide range of corneal irregularities and ocular surface disease, suggesting that PROSE lenses may offer improvements in visual acuity without risks inherent to surgery.
Keywords: Corneal irregularity; Ocular surface disease; Scleral lens; Visual acuity.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
-
Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) scleral device compared to keratoplasty for the treatment of corneal ectasia.Am J Ophthalmol. 2014 Nov;158(5):974-82. doi: 10.1016/j.ajo.2014.07.016. Epub 2014 Jul 21. Am J Ophthalmol. 2014. PMID: 25058902
-
Prosthetic Replacement of the Ocular Surface Ecosystem Scleral Lens Therapy for Exposure Keratopathy.Eye Contact Lens. 2017 Jul;43(4):240-244. doi: 10.1097/ICL.0000000000000265. Eye Contact Lens. 2017. PMID: 27171131
-
Diagnoses and Outcomes of Prosthetic Replacement of the Ocular Surface Ecosystem Treatment-A Canadian Experience.Eye Contact Lens. 2021 Jul 1;47(7):394-400. doi: 10.1097/ICL.0000000000000779. Eye Contact Lens. 2021. PMID: 33769992
-
Scleral lenses for correction of irregular astigmatism: advances and limitations.Curr Opin Ophthalmol. 2025 Jul 1;36(4):282-287. doi: 10.1097/ICU.0000000000001149. Epub 2025 Apr 21. Curr Opin Ophthalmol. 2025. PMID: 40279320 Review.
-
Long-Term Descemetocele Management With Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) Treatment.Eye Contact Lens. 2020 Mar;46(2):e7-e10. doi: 10.1097/ICL.0000000000000602. Eye Contact Lens. 2020. PMID: 30985491 Review.
Cited by
-
Update on indications, complications, and outcomes of scleral contact lenses.Med Hypothesis Discov Innov Ophthalmol. 2022 Feb 24;10(4):165-178. doi: 10.51329/mehdiophthal1435. eCollection 2021 Winter. Med Hypothesis Discov Innov Ophthalmol. 2022. PMID: 37641653 Free PMC article. Review.
-
Corneal blindness in the developing world: The role of prevention strategies.F1000Res. 2024 Mar 5;12:1309. doi: 10.12688/f1000research.141037.2. eCollection 2023. F1000Res. 2024. PMID: 38618022 Free PMC article.
-
A Review of the Diagnosis and Treatment of Limbal Stem Cell Deficiency.Front Med (Lausanne). 2022 May 25;9:836009. doi: 10.3389/fmed.2022.836009. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35692544 Free PMC article. Review.
-
Drug delivery strategies to improve the treatment of corneal disorders.Heliyon. 2025 Jan 10;11(2):e41881. doi: 10.1016/j.heliyon.2025.e41881. eCollection 2025 Jan 30. Heliyon. 2025. PMID: 39897787 Free PMC article. Review.
-
Long-term outcome of using Prosthetic Replacement of Ocular Surface Ecosystem (PROSE) as a drug delivery system for bevacizumab in the treatment of corneal neovascularization.Ocul Surf. 2019 Jan;17(1):134-141. doi: 10.1016/j.jtos.2018.11.008. Epub 2018 Nov 20. Ocul Surf. 2019. PMID: 30468876 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical